Association between methylation quantitative trait loci and colorectal cancer risk, survival and cancer recurrence
Menée à partir de données écossaises portant sur 14 692 témoins et 6 821 patients atteints d'un cancer colorectal, cette étude identifie des loci de méthylation de l'ADN associé au risque de développer la maladie puis analyse leur corrélation avec la survie et la récidive
Background: Epigenetic changes contribute to colorectal cancer (CRC) pathogenesis. We investigated whether methylation quantitative trait loci (mQTLs) are associated with CRC risk, survival and recurrence.
Methods: Using a well-characterised Scottish case-control study (6821 CRC cases, 14,692 controls), we derived 118,982 mQTLs based on the Genetics of DNA Methylation Consortium (GoDMC). Association analysis between mQTLs and CRC risk, survival and recurrence was performed using logistic regression or Cox models respectively. Additionally, colocalisation analysis was performed.
Results: 19 mQTLs within 10 distinct genomic regions were associated with CRC risk. Two novel regions were mapped to MDGA2 (p value = 3.0 x 10-6) and STARD3 (p value = 5.6 x 10-6). Four regions mapped to POU5F1B, POU2AF2 (c11orf53)/POU2AF3 (COLCA2), GREM1 and CABLES2 were previously identified. Four regions mapped to PPA2, PANDAR/LAP3P2, POU6F1 and CTIF contained SNPs previously identified by CRC GWAS but with SNPs annotated to different genes. We found no evidence that any of the 19 mQTLs associated with CRC risk influenced survival or recurrence after FDR correction. Colocalisation analysis suggested that in three of the ten regions the causal variants were shared for methylation and CRC risk.
Conclusion: This study adds to the repertoire of CRC genes. However, we found no associations between methylation and CRC survival or recurrence.
British Journal of Cancer , article en libre accès, 2025